Continuous or Fixed-Duration Maintenance Therapy in Multiple Myeloma

Study limitation reported by the research below: “The trial enrolled only standard-risk, non-transplant patients — findings should not be extrapolated to transplant-eligible or high-risk cytogenetic populations.”